UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

4E-Binding Protein 1, A Cell Signaling Hallmark in Breast Cancer that Correlates with Pathologic Grade and Prognosis

Clinical cancer research, 2007-01, Vol.13 (1), p.81-89

2007

Link zum Volltext

Verfügbarkeit prüfen

Imaging and pathology features to predict axillary tumor load in breast cancer

The journal of obstetrics and gynaecology research, 2018-02, Vol.44 (2), p.331-336

2018

Link zum Volltext

Verfügbarkeit prüfen

Mammographic extent of microcalcifications and oestrogen receptor expression affect preoperative breast carcinoma in situ size estimation

Breast cancer (Tokyo, Japan), 2017-05, Vol.24 (3), p.466-472

2017

Link zum Volltext

Verfügbarkeit prüfen

Cyclo-oxygenase type 2 is dysregulated in breast ductal carcinoma in situ and correlates with poor outcome

European journal of obstetrics & gynecology and reproductive biology, 2010-07, Vol.151 (1), p.72-76

2010

Link zum Volltext

Verfügbarkeit prüfen

p53 expression in breast cancer predicts tumors with low probability of non-sentinel nodes infiltration

The journal of obstetrics and gynaecology research, 2015-07, Vol.41 (7), p.1115-1121

2015

Link zum Volltext

Verfügbarkeit prüfen

Complete Pathological Remission in a Patient with Hormone-Receptor Positive and c-erbB-2 Expression-Negative Breast Cancer Treated with FAC Chemotherapy during Pregnancy

Tumori, 2010-07, Vol.96 (4), p.629-632

2010

Link zum Volltext

Verfügbarkeit prüfen

P47– Update of Clinical Practice Guideline (CPG) on eating disorder treatments

Otolaryngology-head and neck surgery, 2010-07, Vol.143 (1), p.102-102

2010

Link zum Volltext

Verfügbarkeit prüfen

Metástasis ganglionares axilares contalaterales en cáncer de mama: controversia sobre su vía de diseminación, manejo y pronóstico

Revista de senología y patología mamaria, 2016-04, Vol.29 (2), p.86-89

2016

Link zum Volltext

Verfügbarkeit prüfen

Concordance between radiologic and pathologic complete response in patients with breast cancer treated with neoadjuvant chemotherapy

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e12028-e12028

2014

Link zum Volltext

Verfügbarkeit prüfen

Benefit of sentinel node biopsy in patients with breast ductal carcinoma in situ

Cirugia Española, 2009-02, Vol.85 (2), p.92-95

2009

Link zum Volltext

Verfügbarkeit prüfen

Benefit of sentinel node biopsy in patients with breast ductal carcinoma in situ

Cirugia española (English ed.), 2009, Vol.85 (2), p.92-95

2009

Link zum Volltext

Verfügbarkeit prüfen

Beneficio de la biopsia del ganglio linfático centinela en pacientes con carcinoma in situ de mama

Cirugia Española, 2009-02, Vol.85 (2), p.92-95

2009

Link zum Volltext

Verfügbarkeit prüfen

Removal of all radioactive sentinel nodes in breast cancer improves the detection of positive sentinel nodes

Clinical & translational oncology, 2008-06, Vol.10 (6), p.347-350

2008

Link zum Volltext

Verfügbarkeit prüfen

Cellular markers

International journal of gynecology and obstetrics, 2000, Vol.70 (S3), p.C7-C7

2000

Link zum Volltext

Verfügbarkeit prüfen

Qué hubiera pasado si hubiésemos aplicado el Z0011 en nuestro medio? Revisión de los ganglios centinela realizados en los últimos 2 años en nuestro centro

Revista de senología y patología mamaria, 2012-07, Vol.25 (3), p.96-100

2012

Link zum Volltext

Verfügbarkeit prüfen

Los resultados de un estudio de coste-utilidad cuestionan el diagnóstico prenatal de las trisomías 13, 18 y 21, sobre la base del riesgo de la gestante (por su edad o revisado después del cribado ecográfico o bioquímico)

Formación médica continuada en atención primaria, 2004, Vol.11 (6), p.366-366

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(16)

Sprache

Englisch
(11)
Spanisch
(5)

Erscheinungsjahr

n.n

Thema

Breast Neoplasms - Pathology
(8)
Female
(8)
Humans
(8)
Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Adult
(7)
Aged
(6)
Middle Aged
(6)
Ductal Carcinoma In Situ
(4)
Obstetrics & Gynecology
(4)
Oncology
(4)
Retrospective Studies
(4)
Surgery
(4)
Aged, 80 And Over
(3)
Breast
(3)
Breast Cancer
(3)
Breast Neoplasms - Metabolism
(3)
Breast Neoplasms - Surgery
(3)
Carcinoma, Intraductal, Noninfiltrating - Pathology
(3)
Prognosis
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

4E-Binding Protein 1, A Cell Signaling Hallmark in Breast Cancer that Correlates with Pathologic Grade and Prognosis

Imaging and pathology features to predict axillary tumor load in breast cancer

Mammographic extent of microcalcifications and oestrogen receptor expression affect preoperative breast carcinoma in situ size estimation

Cyclo-oxygenase type 2 is dysregulated in breast ductal carcinoma in situ and correlates with poor outcome

p53 expression in breast cancer predicts tumors with low probability of non-sentinel nodes infiltration

Complete Pathological Remission in a Patient with Hormone-Receptor Positive and c-erbB-2 Expression-Negative Breast Cancer Treated with FAC Chemotherapy during Pregnancy

P47– Update of Clinical Practice Guideline (CPG) on eating disorder treatments

Metástasis ganglionares axilares contalaterales en cáncer de mama: controversia sobre su vía de diseminación, manejo y pronóstico

Concordance between radiologic and pathologic complete response in patients with breast cancer treated with neoadjuvant chemotherapy

Benefit of sentinel node biopsy in patients with breast ductal carcinoma in situ

Benefit of sentinel node biopsy in patients with breast ductal carcinoma in situ

Beneficio de la biopsia del ganglio linfático centinela en pacientes con carcinoma in situ de mama

Removal of all radioactive sentinel nodes in breast cancer improves the detection of positive sentinel nodes

Cellular markers

Qué hubiera pasado si hubiésemos aplicado el Z0011 en nuestro medio? Revisión de los ganglios centinela realizados en los últimos 2 años en nuestro centro

Los resultados de un estudio de coste-utilidad cuestionan el diagnóstico prenatal de las trisomías 13, 18 y 21, sobre la base del riesgo de la gestante (por su edad o revisado después del cribado ecográfico o bioquímico)

Suchergebnisse filtern